ArticleCellular and molecular gastroenterology and hepatology2026
OGT-enriched Hepatocyte-derived Extracellular Vesicles Promote Capillarization of Liver Sinusoidal Endothelial Cells in Metabolic Dysfunction-associated Steatotic Liver Disease.
Article in Cellular and molecular gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Extracellular Vesicle-Mediated Local and Systemic Communication in Metabolic Diseases.International journal of molecular sciences · 2026Review
- Liver sinusoidal endothelial cell fenestrations in metabolic liver disease: from molecular mechanisms to therapeutic perspectives.Cell communication and signaling : CCS · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND &
aimsThe global incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) has risen dramatically. The capillarization of liver sinusoidal endothelial cells (LSEC) represents a crucial target for intervention in MASLD. However, the regulatory mechanisms underlying LSEC capillarization in MASLD remain unclear. Angiopoietin-2 (Ang-2) serves as a key regulator of vascularization.
methodsThe role and molecular mechanism of lipotoxic hepatocyte-derived small extracellular vesicles (LTH-sEVs) on LSEC capillarization was assessed in both LSEC and high-fat diet (HFD)-induced MASLD mice. O-linked N-acetylglucosamine transferase (OGT) expression was assessed in serum sEV and liver samples from healthy individuals and patients with MASLD. The O-GlcNAcylation inhibitor Benzyl-α-GalNAc (BAGN) was utilized to HFD-induced MASLD mice.
resultsHere, we showed that LTH-sEV can upregulate the vascularization marker Ang-2 and promote LSEC capillarization in vivo and in vitro. Mechanistically, LTH-sEV may transport O-linked N-acetylglucosamine (O-GlcNAc) glycosyltransferase (OGT) to enhance the O-GlcNAc glycosylation (O-GlcNAcylation) of the hepatocyte nuclear factor 1-alpha (HNF1α) Ser471 site. This process facilitates the nuclear translocation of HNF1α and increases its transcriptional activation of Ang-2, thereby promoting the LSEC capillarization. Serum sEV derived from patients with MASLD exhibit elevated levels of OGT, which are positively correlated with alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. Additionally, BAGN could dose-dependently reduce HNF1α O-GlcNAcylation, thereby alleviating LSEC capillarization and MASLD progression in HFD-induced mice.
conclusionsLTH-sEV may transport OGT to enhance HNF1α O-GlcNAcylation and activate Ang-2 expression regulated by HNF1α transcription, thus promoting LSEC capillarization. Consequently, sEV-derived OGT may serve as a novel diagnostic and therapeutic target for MASLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.